Flagler Health has secured $50 million in Series B funding, bringing its total raised to $63 million. This round, led by Bessemer Venture Partners, will fuel the AI-native platform's expansion in the musculoskeletal healthcare market, which impacts over half of U.S. adults and costs over $400 billion annually. The company aims to leverage this capital to further develop its AI solutions for MSK conditions.